Skip to main content

SAGE for the Early Detection of Cognitive Impairment in Primary Care

Active, not recruiting

This study will test primary care physicians' use of the Self-Administered Gerocognitive Examination (SAGE) and an electronic version during an office visit to identify patients who are cognitively impaired. Doctors will talk with patients if possible to learn about any change in the patient's cognitive skills over the past year. The goal is to determine if screening for cognitive impairment in this way leads to new diagnoses and management outcomes compared to primary care providers who use their current usual method of screening for cognitive impairment during office visits.

Minimum Age Maximum Age Gender Healthy Volunteers
65 Years 89 Years All No
October 14, 2019
December 31, 2020

  • Completion of a nonacute care office visit

  • Diagnosis of mild cognitive impairment or dementia
  • Diagnosis of visual loss or conditions causing visual loss in the medical records 

In this study, older adult patients in central Ohio will visit their primary care providers. Some providers will screen for cognitive impairment using standard methods. Other providers will use the SAGE or eSAGE test and have a conversation with an individual who knows the patient well to ascertain any significant change in the patient's cognitive skills over the past year.

Chart reviews will be conducted on all participants for 60 days from the initial visit, including a review of patient demographics, medical history, and medications. SAGE or eSAGE test results and primary care providers' opinion of the patient's cognitive change will be obtained. Additionally, the charts will be reviewed for the number of referrals for further evaluation/management of potential cognitive impairment (including lab work, neuroimaging, neuropsychology testing, neurology/psychiatry, occupational therapy, physical therapy, speech therapy, counseling, respite care, legal assistance, day care, home health, social work, financial planning, and cognitive research), the initiation of pharmacological interventions for the management of cognitive impairment, and the diagnosis of cognitive impairment. Researchers will also assess why some patients do not complete the SAGE or eSAGE, such as provider time constraints, patient noncompliance, and provider oversight. 

Name City State Zip Status Primary Contact
The Ohio State University
Columbus Ohio 43221

Ohio State University

Name Role Affiliation
Douglas Scharre, MD Principal Investigator Ohio State University

Name Phone Email
Nicole Vrettos, MS 614-366-8642


Self-Administered Gerocognitive Examination (SAGE) for the Early Detection of Cognitive Impairment at Primary Care Provider Visits